LHLabcorp

$312.23+14% 1Y

Is it growing?

Good

Growing: earnings up +33% year on year and operating margin widening (+1.6 points).

2 good, 1 neutral
Revenue trend+6% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −3% a year.

Earnings trend+33% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+1.6 points operating

Trailing-twelve-month operating margin, 10.4% now against 8.8% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is LH growing?

Labcorp has grown revenue 6.5% a year over three years and −2.6% a year over five, with earnings per share compounding at 8.9%.

+6.5%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
−2.6%

Revenue growth, 5-year rate · +6.5% over three · growth has picked up over the last three years

Earnings per share, 3-year rate
+8.9%

Earnings per share, 3-year rate · revenue +6.5% · earnings outgrew revenue: margins or the share count worked for shareholders

Years of annual history on file
19

Years of annual history on file · FY2007 to FY2025, as filed

Details›
Revenue FY2021
$13.1B
Revenue FY2022
$11.9B
Revenue FY2023
$12.2B
Revenue FY2024
$13.0B
Revenue FY2025
$14.0B

Annual income statements as filed with the SEC.